All of those participating received weekly 10-20 minute counselling sessions and were interviewed after 26 weeks to see if they had managed to give up.
After 36 weeks 10.1% of the bupropion group gave up, 3.1% the 150mg bupropion group gave up and 13.9% of the 300mg group were abstaining.
However abstinence rates were lower at the end of the trial than at 12 weeks. Report authors said: ‘These results are critically important because few effective treatment options are available for adolescent smokers who want to quit.’
Archives of Paediatric and Adolescent Medicine (2007) 161:1068-1074